PDF icon PDF herunterladen
Klin Monbl Augenheilkd 2010; 227(5): 388-392
DOI: 10.1055/s-0029-1245289
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Herpes-simplex-Keratitis. Ein kurzer Überblick zur aktuellen Therapie

Herpes Simplex Keratitis. A Short Overview of the Current TherapyW. Behrens-Baumann1
  • 1Universitäts-Augenklinik, Otto-von-Guericke-Universität Magdeburg
Weitere Informationen

Publikationsverlauf

Eingegangen: 4.2.2010

Angenommen: 14.2.2010

Publikationsdatum:
20. Mai 2010 (online)

Auch verfügbar aufeRef
   Lizenzen und Reprints
Preview

Zusammenfassung

In dieser Übersicht werden aktuelle Therapieempfehlungen zur Herpes-simplex-Keratitis gegeben. Dabei sind nach einer Literaturrecherche Daten von 2000 bis einschließlich 2009 zusätzlich zu früheren zusammengefasst. Im Wesentlichen werden die medikamentöse Behandlung der oberflächlichen, epithelialen Keratitis, der tiefen, stromalen Keratitis, der Rezidivprophylaxe und der metaherpetischen Keratitis behandelt. Schließlich wird ein Therapieschema präsentiert.

Abstract

In this review the current recommendations for the treatment of Herpes simplex keratitis are given – based on the literature, especially from 2000 till 2009. The medical treatment of epithelial, deep stromal keratitis, the prevention of recurrences and metaherpetic keratitis are discussed. Finally, a therapy scheme is presented.

Schlüsselwörter

Kornea - Infektiologie - Herpes simplex

Key words

cornea - infectiology - herpes simplex

Literatur

  • 1 Wander A H, Centifanto Y M, Kaufman H E. Strain specificity of clinical isolates of herpes simplex virus.  Arch Ophthalmol. 1980;  98 1458-1461
    Suche in Google Scholar
  • 2 Kaufman H E, Centifanto-Fitzgerald Y M, Varnell E D. Herpes simplex keratitis.  Ophthalmology. 1983;  90 700-706
    Suche in Google Scholar
  • 3 Kaufman H E. Update on antiviral agents.  Ophthalmology. 1985;  92 533-536
    Suche in Google Scholar
  • 4 Kaufman H E. A new understanding of ocular herpetic disease.  Am J Ophthalmol. 1982;  33 119-121
    Suche in Google Scholar
  • 5 Remeijer L, Maertzdorf J, Doornenbal P et al. Herpes simplex virus 1 transmission through corneal transplantation.  Lancet. 2001;  357 442
    Suche in Google Scholar
  • 6 Remeijer L, Maertzdorf J, Buitenwerf J et al. Corneal herpes simplex virus type1 superinfection in patients mit recrudescent herpetic keratitis.  Invest Ophthalmol Vis Sci. 2002;  43  358-363
    Suche in Google Scholar
  • 7 Sundmacher R. Color atlas of herpetic eye disease. A practical guide to clinical management. Berlin Heidelberg: Springer-Verlag; 2009
    Suche in Google Scholar
  • 8 Wilhelmus K R. .Therapeutic interventions for herpes simplex virus epithelial keratitis [Review]. The Cochrane Collaboration. John Wiley and Sons, Ltd; 2009
    Suche in Google Scholar
  • 9 Stránská R, Schuurman R, Nienhuis E et al. Survey of aciclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.  J Clin Virol. 2005;  32  7-18
    Suche in Google Scholar
  • 10 Iwayama S, Ono N, Ohmura Y et al. Antiherpesvirus activities of (1’S,2’R)-9-{[1’,2’-bis(hydroxymethyl)cycloprop-1’yl]methyl}guanine (A-5021) in cell culture.  Antimicrob Agents Chemother. 1998;  42 1666-1670
    Suche in Google Scholar
  • 11 Iwayama S, Ohmura Y, Suzuki K et al. Evaluation of anti-herpesvirus activity of (1’S,2’R)-9-{[1’,2’-bis(hydroxymethyl)cycloprop-1’yl]methyl}guanine (A-5021) in mice.  Antiviral Res. 1999;  42 139-148
    Suche in Google Scholar
  • 12 Itahashi M, Higaki S, Sugahara D et al. A-5021. A new Acyclovir analogue inhibits murine herpetic keratitis.  Cornea. 2008;  27 334-338
    Suche in Google Scholar
  • 13 Sozen E, Avunduk A M, Akyol N. Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial.  Chemotherapy. 2006;  52 29-31
    Suche in Google Scholar
  • 14 Higaki S, Itahashi M, Deai T et al. Effect of oral valaciclovir on herpetic keratitis.  Cornea. 2006;  25 S64-S67
    Suche in Google Scholar
  • 15 Duan R, Vries R D, Osterhaus A DME et al. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.  J Infect Dis. 2008;  198  659-663
    Suche in Google Scholar
  • 16 Bacon T H, Levin M J, Leary J J et al. Herpes simplex virus resistance to Acyclovir and Penciclovir after two decades of antiviral therapy.  Clin Microbiol Rev. 2003;  16 114-128
    Suche in Google Scholar
  • 17 Danve-Szatanek de C, Aymard M, Thouvenot D et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.  J Clin Microbiol. 2004;  42 242-249
    Suche in Google Scholar
  • 18 Power W J, Benedict-Smith A, Hillery M et al. Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration.  Br J Ophthalmol. 1991;  75 649-651
    Suche in Google Scholar
  • 19 Behrens-Baumann W. Phosphonoformate (Foscarnet, PFA) versus Trifluorthymidine in the treatment of keratitis dendritica in the human. A double-blind, randomized, preliminary trial.  Acta Ophthalmol. 1992;  70 690-692
    Suche in Google Scholar
  • 20 Helgstrand E, Eriksson B, Johansson N G et al. Trisodium phosphonoformate, a new antiviral compound.  Science. 1978;  201 819-821
    Suche in Google Scholar
  • 21 Levin M J, Weinberg A, Leary J J et al. Development of Acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.  Pediatric Infect Dis J. 2001;  20 1094-1097
    Suche in Google Scholar
  • 22 Colin J. Ganciclovir ophthalmic gel, 0.15 %: a valuable tool for treating ocular herpes.  Clin Ophthalmol. 2007;  4 441-453
    Suche in Google Scholar
  • 23 Hoh H B, Hurley C, Claoue C et al. Randomised trial of gancoglivir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.  Br J Ophthalmol. 1996;  80 140-143
    Suche in Google Scholar
  • 24 Kaufman H E. Ganciclovir: a promising topical antiviral gel for herpetic keratitis.  Expert Rev Ophthalmol. 2009;  4 367-375
    Suche in Google Scholar
  • 25 Zhang J, Gao C, Wang L. Ocular pharmacokinetics and bioavailability of 0.2 % ganciclovir in-situ gelling eye drops.  Chin J Ophthalmol. 2006;  42 637-641
    Suche in Google Scholar
  • 26 Sundmacher R. Herpestherapie und -prophylaxe.  Klin Monatsbl Augenheilkd. 1976;  169 308-325
    Suche in Google Scholar
  • 27 Behrens-Baumann, W, Weber, U, Ansorg, R Trifluorthymidin und bakterielle Hornhautinfektion. Eine tierexperimentelle Studie. München; 1981: 291-294
    Suche in Google Scholar
  • 28 Behrens-Baumann W, Weber U, Ansorg R. Azyklovir und bakterielle Hornhautinfektion. Eine tierexperimentelle Studie.  Ber Dtsch Ophthalmol Ges. 1981;  78 399-401
    Suche in Google Scholar
  • 29 Yamaguchi K, Okumoto M, Stern G et al. Idoxuridine and bacterial corneal infection.  Am J Ophthalmol. 1979;  87 202-205
    Suche in Google Scholar
  • 30 Barron B A, Gee L, Hauck W W et al. Herpetic eye disease study.  Ophthalmology. 1994;  101 1871-1882
    Suche in Google Scholar
  • 31 Knickelbein J E, Hendricks R L, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review.  Surv Ophthalmol. 2009;  54 226-234
    Suche in Google Scholar
  • 32 Inoue Y. Immunological aspects of herpetic stromal keratitis.  Sem Ophthalmol. 2008;  23 221-227
    Suche in Google Scholar
  • 33 Wilhelmus K R. Diagnosis and management of herpes simplex stromal keratitis.  Cornea. 1987;  6 286-291
    Suche in Google Scholar
  • 34 Collum L MT, Logan P, Ravenscroft T. Acyclovir (Zovirax) in herpetic disciform keratitis.  Br J Ophthalmol. 1983;  67 115-118
    Suche in Google Scholar
  • 35 Wilhelmus K R, Gee L, Hauck W W et al. Herpetic eye disease study.  Ophthalmology. 1994;  101 1883-1896
    Suche in Google Scholar
  • 36 Behrens-Baumann W, Quentin C D, Vogel M. Acyclovir versus Trifluorthymidin in der Therapie der stromalen Herpes-Keratitis.  Klin Monatsbl Augenheilkd. 1986;  189 286-288
    Suche in Google Scholar
  • 37 Pleyer U, Mondino B J, Adamus S A et al. Immune response to Staphylococcus epidermidis endophthalmitis in a rabbit model.  Invest Ophthalmol Vis Sci. 1992;  33  2650-2663
    Suche in Google Scholar
  • 38 Kain H L. Prinzipien in der Behandlung der Endophthalmitis.  Klin Monatsbl Augenheilkd. 1997;  210 274-288
    Suche in Google Scholar
  • 39 Behrens-Baumann W, Paul H H, Ansorg R. Der Einfluss von Cortison bei der Behandlung der Pseudomonas-aeruginosa-Keratitis.  Klin Monatsbl Augenheilkd. 1981;  178 200-202
    Suche in Google Scholar
  • 40 Behrens-Baumann W, Küster M. Der Einfluss von Kortikosteroiden bei der antimykotischen Therapie der Candida-Keratitis.  Klin Monatsbl Augenheilkd. 1987;  191 222-225
    Suche in Google Scholar
  • 41 Schreiber W, Olbrisch A, Vorwerk C K et al. Combined topical fluconazole and corticosteroid treatment for experimental candida albicans keratomycosis.  Invest Ophthalmol Vis Sci. 2003;  44  2634-2643
    Suche in Google Scholar
  • 42 Behrens-Baumann W, Pleyer U. Therapie und Prognose der bakteriellen Keratitis.  Ophthalmologe. 2007;  104 15-20
    Suche in Google Scholar
  • 43 Behrens-Baumann W. Zur aktuellen Therapie der postoperativen Endophthalmitis.  Klin Monatsbl Augenheilkd. 2008;  225 919-923
    Suche in Google Scholar
  • 44 Behrens-Baumann W. Diagnostik und Therapie der Keratomykose.  Ophthalmologe. 2009;  106 471-481
    Suche in Google Scholar
  • 45 Gunduz K, Ozdemir O. Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis.  Ophthalmic Res. 1997;  29 405-408
    Suche in Google Scholar
  • 46 Heiligenhaus A, Steuhl K P. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.  Graefe’s Arch Clin Exp Ophthalmol. 1999;  237 435-438
    Suche in Google Scholar
  • 47 Rao S N. Treatment of herpes simplex Virus stromal keratitis unresponsive to topical prednisolone 1 % with topical cyclosporine 0.05 %.  Am J Ophthalmol. 2006;  141 771-772
    Suche in Google Scholar
  • 48 Heiligenhaus A, Bauer D, Meller D et al. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.  Invest Ophthalmol Vis Sci. 2001;  42 1969-1974
    Suche in Google Scholar
  • 49 Heiligenhaus A, Li H, Hernandez G alindo E E et al. Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation.  Br J Ophthalmol. 2003;  87 1215-1219
    Suche in Google Scholar
  • 50 Shi W, Chen M, Xie L. Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis.  Ophthalmology. 2007;  114 1476-1481
    Suche in Google Scholar
  • 51 Saravia M, Zapata G, Ferraiolo P et al. Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis.  Graefe’s Arch Clin Exp Ophthalmol. 2009;  247 1409-1416
    Suche in Google Scholar
  • 52 Barney N P, Foster C S. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.  Cornea. 1994;  13 232-236
    Suche in Google Scholar
  • 53 Simon A L, Pavan-Langston D. Long-term oral aciclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts.  Ophthalmology. 1996;  103 1399-1405
    Suche in Google Scholar
  • 54 Rooij van J, Rijneveld W J, Remeijer L J et al. A retrospective study on the effectiveness of oral acyclovir to prevent herpes simplex recurrence in corneal grafts.  Eur J Ophthalmol. 1995;  4  214-218
    Suche in Google Scholar
  • 55 Rooij van J, Rijneveld W J, Remeijer L et al. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis. A placebo-controlled multicenter trial.  Ophthalmology. 2003;  110 1916-1919
    Suche in Google Scholar
  • 56 Herpetic Eye Disease Study Group (HEDS) . Acyclovir for the prevention of recurrent herpes simplex virus eye disease.  N Engl J Med. 1998;  339 300-306
    Suche in Google Scholar
  • 57 Uchoa U BC, Rezende R A, Carrasco M A et al. Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection.  Arch Ophthalmol. 2003;  121 1702-1704
    Suche in Google Scholar
  • 58 Miserocchi E, Modorati G, Galli L et al. Efficacy of Valacyclovir vs Acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.  Am J Ophthalmol. 2007;  144 547-551
    Suche in Google Scholar
  • 59 Schwartz G S, Holland E J. Oral acyclovir for the management of herpes simplex virus keratitis in children.  Ophthalmology. 2000;  107 278-282
    Suche in Google Scholar
  • 60 Duan R, Vries R D, Dun van J M et al. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.  J Infect Dis. 2009;  200  1402-1414
    Suche in Google Scholar
  • 61 Kaye de S, Choudhary A. Herpes simplex keratitis.  Progr Ret Eye Res. 2006;  25 355-380
    Suche in Google Scholar
  • 62 Tambasco F P, Cohen E J, Nguyen L H et al. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.  Arch Ophthalmol. 1999;  117 445-449
    Suche in Google Scholar
  • 63 Foster C S, Duncan J. Penetrating keratoplasty for herpes simplex keratitis.  Am J Ophthalmol. 1981;  92 336-343
    Suche in Google Scholar
  • 64 Moyes A L, Sugar A, Musch D C et al. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis.  Arch Ophthalmol. 1994;  112 601-607
    Suche in Google Scholar
  • 65 Kaufman H E. Epithelial erosion syndrome: metaherpetic keratitis.  Am J Ophthalmol. 1964;  57 983-987
    Suche in Google Scholar
  • 66 Kaufman H E. Treatment of oral diseases of the cornea and external eye.  Progr Ret Eye Res. 2000;  19 69-85
    Suche in Google Scholar

Prof. Dr. Wolfgang Behrens-Baumann

Universitäts-Augenklinik, Otto-von-Guericke-Universität Magdeburg

Leipziger Str. 44

39120 Magdeburg

Telefon: ++ 49/3 91/6 71 35 71

Fax: ++ 49/3 91/6 71 35 70

eMail: augenklinik@ovgu.de